Lladó Garriga, LauraIborra Ortega, ElenaRamos Rubio, EmilioSabé, NuriaCachero, AlbaFabregat Prous, Joan2022-02-282022-02-282020-09-011499-3872https://hdl.handle.net/2445/183590Liver transplantation (LT) after neoadjuvant chemoradiotherapy in patients with unresectable hilar cholangiocarcinoma (HC) is an accepted treatment strategy [1]. Neoadjuvant therapy is associated with an increased risk of arterial and portal complications after LT [1,2]. In most cases, radiation therapy makes the use of the native hepatic artery inadvisable, and an aortic anastomosis is needed, either with or without a graft [2]. The development of a mycotic pseudoaneurysm after LT is a rare complication that is associated with a high incidence of graft failure and mortality. Radiotherapy, local infections and the use of grafts are known risk factors for the development of a mycotic pseudoaneurysm, which is always challenging to manage [3].3 p.application/pdfengcc-by-nc-nd (c) Elsevier B.V., 2020https://creativecommons.org/licenses/by-nc-nd/4.0/ArteritisCàncer de fetgeTrasplantament hepàticDerivació cardiopulmonarArteritisLiver cancerHepatic transplantationCardiopulmonary bypassinfo:eu-repo/semantics/article7065362022-02-28info:eu-repo/semantics/openAccess32893144